Skip to main content

Postersession II

Nephrologie 2

  • Conference paper
Book cover 90. Kongreß

Zusammenfassung

Der Einfluß immungenetischer Faktoren auf Entstehung und Progredienz von primären Glomerulonephritiden (GN) ist weitgehend ungeklärt. Die HLA-Region ist das zentrale „Kontrollorgan“ für die Immunantwort des Menschen [2]. Deshalb wurde inzwischen in mehreren Studien eine mögliche Assoziation bestimmter HLA-Allele mit verschiedenen Formen von primärer GN untersucht (Übersichtsarbeit [4]). Der generelle Nachteil solcher Untersuchungen liegt in der relativen Häufigkeit vieler HLA-Antigene in der Normalbevölkerung, wodurch die Aussagekraft für das Patientenkollektiv oftmals unbefriedigend ist. Es schien uns daher sinnvoll nach weiteren möglichst präzisen immungenetischen Markern zu fahnden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Awdeh ZL, Alper CA (1980) Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci USA 77: 3576–3580

    Article  PubMed  CAS  Google Scholar 

  2. Bach FH, van Rood JJ (1976) The major histocompatibility complexgenetics and biology. N Engl J Med 295: 806–813

    Article  PubMed  CAS  Google Scholar 

  3. O’Neill GJ, Yang SY, Dupont B (1978) Two HLA–linked loci controlling the fourth component of human complement. Proc Natl Acad Sci USA. 75: 5154–5169

    Google Scholar 

  4. Rashid HU, Papiha SS, Agroyannis B, Morely AR, Ward MK, Roberts DF, Kerr DNS (1983) The associations of HLA and other genetic markers with glomerulonephritis. Hum Genet 63: 38–44

    Article  PubMed  CAS  Google Scholar 

  5. Terasaki PI, McClelland LP (1964) Microdroplet assay of human serum cytotoxins. Nature 204: 998–1000

    Article  PubMed  CAS  Google Scholar 

  6. Arendshorst WJ, Finn WF, Gottschalk CW (1975) Pathogenesis of acute renal failure following temporary renal ischemia in the rat. Circ Res 37: 558–568

    Article  PubMed  CAS  Google Scholar 

  7. Burke TJ, Arnold PE. Grossfeld RW, Schrier RW (1982) Effect of calcium membrane inhibition on norepinephrine–induced acute renal failure. In: Eliahou HE (ed) Acute renal failure. J Libbey, London, pp 239–240

    Google Scholar 

  8. Chan L, Ledingham JGG. Dixon JA, Thulborn KR, Waterton JC, Radda GK, Ross BD (1982) Acute renal failure: a proposed mechanism based upon 31P nuclear magnetic resonance. In: Eliahou HE (ed) Acute renal failure. J Libbey, London, pp 35–41

    Google Scholar 

  9. Epstein FH, Balaban RS. Ross BD (1982) Mitochondrial anoxia in intact perfused kidney. In: Eliahou HE (ed) Acute renal failure. J Libbey, London, p 297

    Google Scholar 

  10. Gerlach E, Deuticke B, Dreisbach RH, Rosarius CW (1963) Zum Verhalten von Nucleotiden and ihren dephosphorylierten Abbauprodukten in der Niere bei Ischämie and kurzzeitiger postischämischer Wiederdurchblutung. Pflügers Arch 278: 296–315

    Article  CAS  Google Scholar 

  11. Minuth AN, Terell JB jr, Suki WN (1976) Acute renal failure: a study of the course and prognosis of 104 patients and the role of furosemid. Am J Med Sci 271: 317–324

    Article  PubMed  CAS  Google Scholar 

  12. Smolens P, Stein JH (1981) Pathophysiology of acute renal failure. Am J Med 70: 479–482

    Article  PubMed  CAS  Google Scholar 

  13. Wilson DR, Arnold PE, Burke TJ, Schrier RW (1984) Mitochondria] calcium accumulation and respiration in ischemic acute renal failure in the rat. Kidney Int 25: 519–526

    Article  PubMed  CAS  Google Scholar 

  14. Schreiner GE (1963) The nephrotic syndrome. In: Strauss/Welt (eds) Disease of the kidney. Little, Brown & Co, Boston, p 335

    Google Scholar 

  15. Scribner BH, Goldstein HH, Rifkin H (1974) in discussion: the problem of end stage nephropathy. Kidney Int 6: S21 — S26

    Google Scholar 

  16. Kussman MJ, Goldstein HH, Gleason RE (1976) The clinical course of diabetic nephropathy. JAMA 236: 1861–1863

    Article  PubMed  CAS  Google Scholar 

  17. Warms PC, Rosenbaum BJ, Michelis MF, Haas JE (1973) Idiopathic membranous glomerulonephritis occurring with diabetes mellitus. Arch Intern Med 132: 725–738

    Article  Google Scholar 

  18. Murphy WM, Deodhar SD, McCormack LJ, Osborne DG (1973) Immunopathologic studies in glomerular diseases with membranous lesions. Am J Clin Pathol 60: 364–376

    PubMed  CAS  Google Scholar 

  19. Sharma HM, Yum MN, Kleit S (1974) Acute glomerulonephritis with diabetes mellitus. Arch Pathol 97: 152–154

    PubMed  CAS  Google Scholar 

  20. Olivero J, Suki WN (1977) Acute glomerulonephritis complicating diabetic nephropathy. Arch Intern Med 137: 732–734

    Article  PubMed  CAS  Google Scholar 

  21. Wass JAH, Watkins PJ, Dische EF, Parsons V (1978) Renal failure, glomerular disease and diabetes mellitus. Nephron 21: 289–296

    Article  PubMed  CAS  Google Scholar 

  22. Rao KV, Crosson JT (1980) Idiopathic membranous glomerulonephritis in diabetic patients. Arch Intern Med 140: 624–627

    Article  Google Scholar 

  23. Kasinath BS, Mujais SK, Spargo BH, Katz AJ (1983) Nondiabetic renal disease in patients with diabetes mellitus. Am J Med 75: 613–617

    Article  PubMed  CAS  Google Scholar 

  24. McCrary RF, Pitts TO, Puschett JB (1981) Diabetic nephropathy: natural cours, survivorship and therapy. Am J Nephrol 1: 206–218

    Article  PubMed  CAS  Google Scholar 

  25. Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, Grassi C, Limido D, Pasquali S, Volpini T, Sasdelli M, Locatelli F (1984) Controlled trial of methylprednisolon and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 310: 946–950

    Article  PubMed  CAS  Google Scholar 

  26. Watkins PJ, Blainey JD, Brewer DB, Fitzgerald MG, Malins JM, O’Sullivan DJ, Pinto JA (1972) The natural history of diabetic renal disease. A follow–up study of a series of renal biopsies. Q J Med 41: 437–456

    Google Scholar 

  27. Goto Y (1978) Vascular complications in diabetes in Japan. Adv Metab Disord 9: 167–200

    PubMed  CAS  Google Scholar 

  28. Acharya VN, Chawla KP (1978) Diabetic nephropathy a review. J Postgr Med 24: 138–146

    CAS  Google Scholar 

  29. Ben–Bassat M, Boner G, Rosenfeld J, Pick AI, Kahana M, Hazaz B, Hochman B (1983) The clinicopathologic features of cryoglobulinemicnephropathy. Am J Clin Pathol 79: 147–156

    Google Scholar 

  30. Brouet J–C, Clauvel J–P, Danon F, Klein M, Seligmann M (1974) Biological and clinical significance of cryoglobulins Am J Med 57: 775–788

    CAS  Google Scholar 

  31. De Vecchi A, Montagnino G, Pozzi C, Tarantino A, Locatelli F, Ponticelli C (1983) Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy. Clin Nephrol 19: 221–227

    PubMed  Google Scholar 

  32. Franklin EC (1980) Cryoproteins. In: Parker CW (ed) Clinical immunology, Vol 1. Saunders, Philadelphia London Toronto, p 534

    Google Scholar 

  33. Gamble CN, Ruggles SW (1978) The immunopathogenesis of glomerulonephritis associated with mixed cryoglobulinemia. N Engl J Med 299: 81–85

    Article  PubMed  CAS  Google Scholar 

  34. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, Franklin EC (1980) Mixed cryoglobulinemia: clinical aspects and long term follow–up of 40 patients. Am J Med 69: 287–308

    Article  PubMed  CAS  Google Scholar 

  35. Grey HM, Köhler PF (1973) Cryoimmunoglobulins. Sem in Hematol 10: 87–112

    CAS  Google Scholar 

  36. Matuhasi T, Usui M, Mizuno N (1968) yA–yG–mixed cryoglobulin. Jpn J Exp Med 38: 205–211

    Google Scholar 

  37. Mookerjee BK, Maddison PJ, Reichlin M (1978) Mesangial IgA–IgG deposition in mixed cryoglobulinemia. Am J Med Sci 276: 221–225

    Article  PubMed  CAS  Google Scholar 

  38. Shumak KH, Rock GA (1984) Therapeutic plasma exchange. N Engl J Med 310: 762–771

    Article  PubMed  CAS  Google Scholar 

  39. Takeda K, Okumura H, Hirose S, Muranaka M (1974) Immuno–and physicochemical studies of an IgA–IgG mixed cryoglobulin. Int Arch Allergy 46: 38–52

    Article  PubMed  CAS  Google Scholar 

  40. Wagner O, Mustakallio KK, Räsänen JA (1968) Mixed IgA–IgG cryoglobulinemia. Am J Med 44: 179–187

    Article  Google Scholar 

  41. Whitsed HM, Penny R (1971) IgA/IgG cryoglobulinemia with vasculitis. Clin Exp Immunol 9: 183–191

    PubMed  CAS  Google Scholar 

  42. Zollinger HU, Mihatsch MJ (1978) Renal pathology in biopsy. Springer, Berlin Heidelberg New York, p 169

    Chapter  Google Scholar 

  43. Ackrill P, Ralston HJ, Day JP, Hodge KC (1980) Successful removal of aluminium from patients with dialysis encephalopathy. Lancet 2: 692–693

    Article  PubMed  CAS  Google Scholar 

  44. Alfrey AC, Mishell JB, Burks J, Contiguglia SR, Rudolph H, Lewin E, Holmes JH (1972) Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs 18: 257–261

    Article  PubMed  CAS  Google Scholar 

  45. Alfrey AC, LeGendre GR, Kaehny WD (1976) The dialysis encephalopathy syndrome. N Engl J Med 294: 184–188

    Article  PubMed  CAS  Google Scholar 

  46. Cornells R (1982) Variability in reported plasma AI–concentrations. Int. Workshop on: The role of biological monitoring in the prevention of aluminium toxicity in man. Commission of the European Communities, Luxembourg, 5–7 July, 1982

    Google Scholar 

  47. Elliot HL, MacDougall AT (1978) Aluminium studies in dialysis encephalopathy. Proc Eur Dial Transplant Assoc 15: 157

    Google Scholar 

  48. Zumkley H, Knoll O, Graefe U, Bertram HP (1983) Klinik der Dialyse–Encephalopathie (im Druck )

    Google Scholar 

  49. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW (1981) Kidney Int 19: 593–602

    Article  PubMed  CAS  Google Scholar 

  50. Boesken WH, Mamier A, Ziupa J (1983) Abstr 5th Europ Congr Clin Chem, p 149

    Google Scholar 

  51. Diskin CJ, Ho G (1981) Rhode Island Med J 64: 521–525

    CAS  Google Scholar 

  52. Felgenhauer K, Ackermann R, Schliep G (1980) J Neurol Sci 47: 21–34

    Article  PubMed  CAS  Google Scholar 

  53. Mancini G, Carbonara AO, Heremans JF (1965) Immunochemistry 2: 235–254

    Article  PubMed  CAS  Google Scholar 

  54. Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski Z, Pyle WK (1978) Ann Intern Med 88: 449–456

    Article  PubMed  CAS  Google Scholar 

  55. Rubin J, McFarland S, Hellems EW, Bower JD (1981) Kidney Int 19: 460–464

    Article  PubMed  CAS  Google Scholar 

  56. Steinhauer HB, Hertting G (1981) Eur J Pharmacol 69: 199–203 — 9. Wardle EN (1973) Br Med J 2: 518

    Google Scholar 

  57. Yatzidis H (1977) Clin Chem 23: 811–812

    PubMed  CAS  Google Scholar 

  58. Ono K, Tatsukawa R, Wakimoto T (1975) Migration of plasticizer from hemodialysis blood tubing. JAMA 234: 141–145

    Article  Google Scholar 

  59. Gibson ThP, Briggs WA, Boone BJ (1976) Delivery of di–2–ethylhexyl phthalate to patients during hemodialysis. J Lab Clin Med 87: 519–524

    PubMed  CAS  Google Scholar 

  60. Bommer J, Ritz E, Andrassy K (1984) Effects secondaires des materiels utilises en hémodialyse. Actual Néphrol (in press)

    Google Scholar 

  61. Ljunggren (1984) Plasticizer migration from blood lines in hemodialysis. Int J Artif Org 8: 99–102

    Article  CAS  Google Scholar 

  62. Jacobson MS, Kevy SV, Grand RJ (1977) Effects of plasticizer leached from polyvinyl chloride on the subhuman primate: a consequence of chronic transfusion therapy. J Lab Clin Med 89: 1066

    PubMed  CAS  Google Scholar 

  63. Jacobson MS, Kevy SV, Parkman R, Wesolowski JS (1980) An in vitro evaluation of a new plasticizer for polyvinylchloride medical devices. Transfusion 20: 443–447

    Article  PubMed  CAS  Google Scholar 

  64. Patterson R, Roberts M, Zeiss RC, Pruzansky JJ (1981) Human antibodies against trimellity proteins: comparison of sepcificities of IgG, IgA and IgE classes. Int Arch Allergy Appl Immunol 66: 332–340

    Google Scholar 

  65. Baldamus CA, Ernst W, Lysaght MJ, Shaldon S, Koch KM (1983) Hemodynamics in hemofiltration. Int J Artif Org 6: 27–31

    CAS  Google Scholar 

  66. Elcayamu U, Gardin JM, Berkley R, Houghes CA, Henry WL (1983) The use of Doppler flow velocity measurement to assess the hemodynamic response to vasodilators in patients with heart failure. Circulation 67: 377–381

    Article  Google Scholar 

  67. Huntsman LL, Stewart DK, Barnes SR, Franklin SB, Colocousis JS, Hessel EA (1983) Noninvasive Doppler determination of cardiac output in man. Clinical validation. Circulation 67: 593–602

    Google Scholar 

  68. Quellhorst I, Schünemann B, Hildebrandt U, Falda Z (1980) Response of the vascular system to different modifications of hemofiltration and hemodialysis. Proc EDTA 17: 197–204

    CAS  Google Scholar 

  69. Trompler AT, Sold G, Vogt A, Kreuzer H (1984) Nichtinvasive Messung des Herzzeitvolumens mit quantitativer Doppler–Echokradiographie. Z Kardiol (Suppl l) 73: 37

    Google Scholar 

  70. Valdes–Cruz LM, Sahn DJ (1982) Two dimensional echo Doppler for non–invasive quantitation of cardiac flow: a status report. Mod Concepts Cardiovasc Dis 51: 123–128

    Google Scholar 

  71. Rosenbaum J, Winsten S, Kramer MS, Moros J, Raja R (1970) Resin hemoperfusion in the treatment of drug intoxication. Trans Am Soc Artif Intern Organs 16: 134

    PubMed  CAS  Google Scholar 

  72. Heath A, Delin K, Eden E, Martensson E, Selander D, Wickström J, Ahlem J (1980) Hemoperfusion with amberlite resin in the treatment of selfpoisoning. Acta Med Scand 207: 455

    Article  PubMed  CAS  Google Scholar 

  73. Ludlam CA, Bolton AE, Moore S, Cash JD (1975) New rapid method for diagnosis of deep venous thrombosis. Lancet 2: 259–260

    Article  PubMed  CAS  Google Scholar 

  74. European Multicenter Trial (1982) Cyclosporin A as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Lancet 2: 57–60

    Google Scholar 

  75. Foegh ML, Winchester JF, Zmudka M, Helferich GB, Cooly C, Ramwell PW, Schreiner GE (1981) Urine i–TXB2 in renal allograft rejection. Lancet 2: 431–434

    Article  PubMed  CAS  Google Scholar 

  76. Hemmingsen L, Jensen H, Skaarup P (1976) The urinary excretion of ten plasma proteins in long–term transplant patients. Acta Med Scand 199: 311–316

    Article  PubMed  CAS  Google Scholar 

  77. Klintmalm GMG, Iwatsuki S, Starzl TE (1981) Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet 1: 470–471

    Article  PubMed  CAS  Google Scholar 

  78. Steinhauer HB, Lubrich I, Giinter B, Schollmeyer P (1983) Response of human platelets to inhibition of thromboxane synthesis. Clin Hemorheol 3: 1–12

    CAS  Google Scholar 

  79. Steinhauer HB, Wilms H, Sczesny C–M, Schollmeyer P (1984) Thromboxane B2 as marker of renal allograft rejection. Platelets Prostaglandins and the Cardiovascular System, Florence, February 8–11, Abstract C32

    Google Scholar 

  80. Uthmann U, Geisen HP, Dreikorn K, Röhl L, Horsch R, Rössler W (1980) Diagnostic and prognostic value of 132–microglobulin in renal transplantation. Transplant Clin Immunol 12: 259–265

    Google Scholar 

  81. Winchester JF, Gelfand MC, Foegh ML, Helferich GB, Schreiner GE (1983) Early indicators of renal allograft rejection. Kidney Int 23: S34 — S40

    Google Scholar 

  82. Cunnigham J, Vandenburg MJ, Holly IM, Goodwin FJ (1981) Impaired response of plasma renin activity to tilting after renal transplantation. Clin Sci 61: 69

    Google Scholar 

  83. Curtis J, Luke R, Dustan H, Kashgarian M, Wheelchei J, Jones P, Diethelm A (1983) Remission of essential hypertension after renal transplantation. N Engl J Med 309: 1009

    Article  PubMed  CAS  Google Scholar 

  84. Brecht H, Ernst W, Koch K (1976) Plasma noradrenaline levels in regular haemodialysis patients. Proc Eur Dial Transplant Nephrol 12: 281

    CAS  Google Scholar 

  85. Diethelm A, Hartley M, Adrete J, Sterling W, Morgan J (1975) Treatment of accelerated hypertension and endstage renal failure by bilateral nephrectomy and renal transplantation. Surg Gynecol Obstet 140: 161

    PubMed  CAS  Google Scholar 

  86. McGrath BP, Ledingham GG, Benedict CR (1978) Catecholamines in peripheral venous plasma in patients on chronic haemodialysis. Clin Sci Mol Med 55: 89

    PubMed  CAS  Google Scholar 

  87. Smith R, Reid J, Warren D (1981) Adrenergic components of hypertension after renal transplantation. Clin Sci 61: 1875

    Google Scholar 

  88. Lüthgens M, Schlegel G (1980) CEA+TPA in der klinischen Tumordiagnostik, insbesondere des Mamma–Karzinoms. Tumor Diagnostik 2: 63–77

    Google Scholar 

  89. Björklund B (1980) On the nature and clinical use of tissue polypeptide antigen (TPA). Tumor Diagnostik 1: 9–20

    Google Scholar 

  90. Vorlaender KO (1983) Krebsdiagnostik durch immunologische Tumor–Marker. Diagnostik 16: 11–22

    Google Scholar 

  91. Vorlaender KO (1983) Tumordiagnostik unter Verwendung immunologischer Tumor–Marker. Wien Med Wochenschr 133: 59–66

    PubMed  CAS  Google Scholar 

  92. von Kleist S (1983) Das karzinoembryonale Antigen (CEA). Schattauer, Stuttgart New York, S 33

    Google Scholar 

  93. Alatas H, Scharer K (1975) Wirkung von L–Histidin auf die Stickstoffbilanz bei Kindern mit chronischer Niereninsuffizienz. Nieren–Hochdruckkrankh 4: 67–71

    Google Scholar 

  94. Bergstrom J, Fürst P, Josephson B, Norée L–O (1972) Factors affecting in nitrogen balance in chronic uremic patients receiving essential amino acids intravenously or by mouth. In: Kluthe R, Berlyne G, Burton B (eds) Uremia. Thieme, Stuttgart

    Google Scholar 

  95. Essers U (1982) In: Losse H, Renner E (Hrsg). Klinische Nephrologie, Bd I. Thieme, Stuttgart

    Google Scholar 

  96. Giordano C, de Santo NG, Rinaldi S, de Pascale C, Pluvio M (1972) Histidine and glycine essential amino acids in uremia. In: Kluthe R, Berlyne G, Burton B (eds) Uremia. Thieme, Stuttgart

    Google Scholar 

  97. Giordano C, de Santo NG, Rinaldi S, Acone D, Esposito R, Gallo B (1973) Histidine dupplements in the treatment of uremic anaemia. Proc. Xth Congr. EDTA 1973. Pitman Medical, vol X, p 160. Bath

    Google Scholar 

  98. Jontofsohn R, Katz N, Stuber U, Kluthe R (1974) Einfluß von L–Histidin und Eisen auf die Anämie bei chronischer Niereninsuffizienz. Nieren–Hochdruckkrankh 3: 28–31

    Google Scholar 

  99. Lindenau K, Schmicker R, Cernacek P, Precht K, Spustova V, Dzurik R (1980) Indications for histidine substitution in RDT patients. In: Partsch G, Batsford S (eds) Histidine II. Thieme, Stuttgart

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Feucht, H.E. et al. (1984). Postersession II. In: 90. Kongreß. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 90. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-85457-6_65

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85457-6_65

  • Publisher Name: J.F. Bergmann-Verlag, Munich

  • Print ISBN: 978-3-8070-0342-9

  • Online ISBN: 978-3-642-85457-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics